Gallant, J. E., Thompson, M., DeJesus, E., Voskuhl, G. W., Wei, X., Zhang, H., . . . Martin, H. (2017). Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults. Journal of acquired immune deficiency syndromes (1999), 75(1), 61-66. https://doi.org/10.1097/QAI.0000000000001306
Citace podle Chicago (17th ed.)Gallant, Joel E., et al. "Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults." Journal of Acquired Immune Deficiency Syndromes (1999) 75, no. 1 (2017): 61-66. https://doi.org/10.1097/QAI.0000000000001306.
Citace podle MLA (9th ed.)Gallant, Joel E., et al. "Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults." Journal of Acquired Immune Deficiency Syndromes (1999), vol. 75, no. 1, 2017, pp. 61-66, https://doi.org/10.1097/QAI.0000000000001306.